BACK TO OVERVIEW

Enabling the scientific community to develop better drugs faster

PipeBio enables the scientific community to develop better drugs, 10x faster. PipeBio's no-code, cloud-based SaaS tool builds bioinformatics solutions to help optimize development of antibodies and antibody-like-therapeutics.

VERTICAL
HealthTech
Country
Denmark
INvested in
Pre-Seed
2021
Invested with
No items found.
Collective contributions

Meet the founders

Jannick Bendtsen

CEO

Owen Bodley

CTO

Related news

External
October 29, 2021

Why We Invested in PipeBio: no-code SaaS for bioinformatics and drug development

The human costs of the pandemic forced the scientific community to rethink how processes, such as drug development, can be done 10x faster than before. PipeBio is at the frontline of that development.
Investment Thesis
October 29, 2021

Why We Invested in PipeBio: no-code SaaS for bioinformatics and drug development

The human costs of the pandemic forced the scientific community to rethink how processes, such as drug development, can be done 10x faster than before. PipeBio is at the frontline of that development.

Delete me when done